Ifosfamide, Mesna and Epirubicin as Second-Line Chemotherapy in Advanced Breast Cancer

MLA

Esmen Baltali, et al. “Ifosfamide, Mesna and Epirubicin as Second-Line Chemotherapy in Advanced Breast Cancer.” Journal of Chemotherapy, vol. 8, Jan. 1996, pp. 310–14. EBSCOhost, https://doi.org/10.1179/joc.1996.8.4.310.

APA

Esmen Baltali, Ibrahim Gullu, Ayse Kars, Mustafa Benekli, Gülten Tekuzman, Ismail Celik, Nilüfer Güler, Sedat Kiraz, Dincer Firat, & Ibrahim Barista. (1996). Ifosfamide, Mesna and Epirubicin as Second-Line Chemotherapy in Advanced Breast Cancer. Journal of Chemotherapy, 8, 310–314. https://doi.org/10.1179/joc.1996.8.4.310

Chicago

Esmen Baltali, Ibrahim Gullu, Ayse Kars, Mustafa Benekli, Gülten Tekuzman, Ismail Celik, Nilüfer Güler, Sedat Kiraz, Dincer Firat, and Ibrahim Barista. 1996. “Ifosfamide, Mesna and Epirubicin as Second-Line Chemotherapy in Advanced Breast Cancer.” Journal of Chemotherapy 8 (January): 310–14. doi:10.1179/joc.1996.8.4.310.